|

Markets: Emerging supply-chain imbalances stand out as a risk – Morgan Stanley

As is often the case with bull markets, a lengthy run of good news and better-than-expected economic data has helped propel stocks to all-time highs. Investor risk-taking has increased, and confidence has begun turning into complacency. Now, new risks are emerging. Key among them: mounting supply-chain woes that are making it harder for businesses to keep up with soaring demand, Lisa Shalett, Chief Investment Officer, Wealth Management at Morgan Stanley briefs.

See: Four key reasons why eurozone equities will outperform their US peers in the remainder of 2021 – CE

Reasons for concern have begun to materialize amid new stock-market highs

“The supply-chain imbalances are becoming so severe that their risks go beyond the short-lived bout of inflation that many analysts predicted. Rising real-time production delays could crimp sales and drag down corporate earnings and economic growth.”

“Supply-chain pressures aren’t the only concerns. In the weeks and months ahead, investors may also want to be cautious about: Soaring home prices: The decline in housing affordability could stall one of the most important engines of US economic growth. High levels of margin debt: Margin debt has grown 72% YoY to levels that have often preceded stock-market declines. Policy headwinds: Policy could become a headwind this fall, as Federal Reserve officials begin to discuss a timetable for tapering bond purchases and Congress debates tax and stimulus plans.”

“Consider that positive economic surprises and the pace of earnings forecast revisions may be peaking. As such, investors may want to begin slowing their deployment of cash into US equities, while they await better entry points into the market, such as a resumption of positive earnings revisions or a US market correction. We also suggest favoring non-US stocks over the next six to nine months.”

Author

FXStreet Insights Team

The FXStreet Insights Team is a group of journalists that handpicks selected market observations published by renowned experts. The content includes notes by commercial as well as additional insights by internal and external analysts.

More from FXStreet Insights Team
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.